Medicare Pilot Program Sparks Controversy Over AI-Driven Treatment Denials

In early February, Michael Edgerly, struggling with degenerative disc disease and scoliosis, was advised by his doctor to receive an epidural steroid injection for severe back pain. Despite coverage by traditional Medicare insurance, Edgerly encountered a denial for this treatment in early March. He is one of many Medicare patients in Washington facing challenges accessing necessary medical care.

The denials are linked to a January pilot program by Medicare requiring doctors to obtain approval from a third-party contractor utilizing AI-driven technology before certain procedures, including epidural steroid injections. This initiative aims to assess and potentially curtail unnecessary medical expenses and is currently active in Washington and five other states. Reports show that the completion time for some medical procedures has increased, now taking up to four times longer than before the pilot's start.

Concerns Over AI-Driven Delays

The program has stirred significant concern among lawmakers. During recent congressional discussions, Washington representatives questioned Secretary of Health and Human Services Robert F. Kennedy Jr. about the pilot's negative impacts. Sen. Maria Cantwell voiced concerns that AI technology is being utilized as a "denial device," as highlighted by reports regarding the Medicare initiative.

Named the "Wasteful and Inappropriate Service Reduction" or "WISeR," the pilot aims to reduce unnecessary Medicare spending. However, it has been critiqued for leading to wrongful denials, causing patient distress and hindering access to essential care. Washington residents have shared personal experiences of facing denials under WISeR, which demand considerable effort to challenge.

Call for Enhanced Oversight

Sen. Cantwell has called for improved oversight and quicker response times, emphasizing the need for human accountability in each denial explanation. The Centers for Medicare and Medicaid Services (CMS) expressed willingness to adapt the pilot, ensuring that any unwarranted barriers are addressed. According to a CMS spokesperson, "CMS is closely monitoring implementation, including turnaround times and denial patterns, actively addressing issues as they surface."

Virtix Health, a Phoenix-based tech company, administers the pilot in Washington. Public details about Virtix remain sparse, though the company gains financially from Medicare savings through the pilot. Initial reports of lengthy response times have reportedly improved, but some healthcare providers still report delays, with approvals taking from 15 to 20 days.

The Washington State Hospital Association's survey highlights prolonged wait times associated with the pilot, significantly surpassing standard timelines. Jennifer Brackeen, WSHA's senior director, noted increasing patient complaints about these delays, emphasizing hospitals' compliance with new procedural requirements.

Some legislators, like Rep. Suzan DelBene, advocate for ending the pilot, arguing that traditional Medicare historically didn't require prior authorization—a step seen as unnecessary that could result in more widespread approval delays. Edgerly's ordeal involved an appeal process after an initial denial, leading to a seven-week wait for a procedure recommended in February, underscoring the significant physical and emotional toll of such protracted processes.